河北(bei)(bei)天成(cheng)(cheng)藥(yao)業(ye)(ye)(ye)股(gu)(gu)份(fen)有限(xian)(xian)公(gong)(gong)(gong)司(si)(si)(si)始建(jian)于(yu)1970年(nian),1998年(nian)由國有企(qi)(qi)(qi)業(ye)(ye)(ye)改(gai)制為有限(xian)(xian)公(gong)(gong)(gong)司(si)(si)(si),是滄州(zhou)市十(shi)家改(gai)制企(qi)(qi)(qi)業(ye)(ye)(ye)之一(yi),也是一(yi)家虧損(sun)企(qi)(qi)(qi)業(ye)(ye)(ye)改(gai)制成(cheng)(cheng)功的企(qi)(qi)(qi)業(ye)(ye)(ye)。2010年(nian)3月改(gai)制為股(gu)(gu)份(fen)有限(xian)(xian)公(gong)(gong)(gong)司(si)(si)(si),河北(bei)(bei)天成(cheng)(cheng)藥(yao)業(ye)(ye)(ye)股(gu)(gu)份(fen)有限(xian)(xian)公(gong)(gong)(gong)司(si)(si)(si)除母公(gong)(gong)(gong)司(si)(si)(si)以外(wai)還下設兩(liang)個(ge)公(gong)(gong)(gong)司(si)(si)(si),即:“河北(bei)(bei)道(dao)恩藥(yao)業(ye)(ye)(ye)有限(xian)(xian)公(gong)(gong)(gong)司(si)(si)(si)”,“河北(bei)(bei)天成(cheng)(cheng)藥(yao)業(ye)(ye)(ye)股(gu)(gu)份(fen)有限(xian)(xian)公(gong)(gong)(gong)司(si)(si)(si)滄州(zhou)渤海分公(gong)(gong)(gong)司(si)(si)(si)(河北(bei)(bei)諾特藥(yao)業(ye)(ye)(ye)有限(xian)(xian)公(gong)(gong)(gong)司(si)(si)(si))”,已形成(cheng)(cheng)藥(yao)物(wu)研發(fa)、原料藥(yao)、制劑全(quan)產(chan)業(ye)(ye)(ye)鏈,原料藥(yao)企(qi)(qi)(qi)業(ye)(ye)(ye)坐落(luo)在(zai)臨港經濟(ji)開發(fa)區(qu),制劑企(qi)(qi)(qi)業(ye)(ye)(ye)坐落(luo)在(zai)滄州(zhou)市經濟(ji)開發(fa)區(qu),是滄州(zhou)市大型的綜合性制藥(yao)企(qi)(qi)(qi)業(ye)(ye)(ye)。公(gong)(gong)(gong)司(si)(si)(si)產(chan)品暢銷(xiao)(xiao)全(quan)國31個(ge)省市及地區(qu),部分產(chan)品遠銷(xiao)(xiao)到(dao)東歐、東南(nan)亞、中(zhong)亞、南(nan)美洲和(he)非洲等30多個(ge)地區(qu)和(he)國家。
目前(qian),公(gong)司現(xian)有(you)(you)(you)職工(gong)1000多人(ren)(ren)、擁(yong)有(you)(you)(you)碩(shuo)士(shi)研究生(sheng)以上學歷人(ren)(ren)員60余人(ren)(ren),大學生(sheng)350余人(ren)(ren),中(zhong)高(gao)級(ji)專業職稱者230人(ren)(ren),專職質(zhi)(zhi)檢人(ren)(ren)員120人(ren)(ren)。公(gong)司在高(gao)速發展的同時(shi),一直大力發展新(xin)產(chan)(chan)品(pin)(pin)研發工(gong)作。目前(qian)已經成(cheng)功投產(chan)(chan)的新(xin)藥(yao)產(chan)(chan)品(pin)(pin)和國內仿制藥(yao)產(chan)(chan)品(pin)(pin)有(you)(you)(you):平(ping)衡(heng)鹽沖(chong)洗(xi)液(ye)(ye)(ye)、木糖(tang)醇氯(lv)化鈉注射(she)液(ye)(ye)(ye)(新(xin)藥(yao))、α-酮酸片、阿魏酸鈉、注射(she)用(yong)轉化糖(tang)、注射(she)用(yong)磷(lin)酸肌酸鈉、復方(fang)電解質(zhi)(zhi)注射(she)液(ye)(ye)(ye)等。目前(qian),公(gong)司已經開發了新(xin)藥(yao)品(pin)(pin)種3個(ge),仿制新(xin)藥(yao)20多個(ge),落戶(hu)產(chan)(chan)品(pin)(pin)16個(ge)。2019年,我公(gong)司實(shi)現(xian)銷售(shou)收入(ru)近10億(yi)元(yuan),全年研發投入(ru)近3600萬元(yuan)。目前(qian),公(gong)司積(ji)極(ji)主動地謀求以脂質(zhi)(zhi)體抗癌、心腦血管(guan)、腫(zhong)瘤、免疫調節等代謝類疾病用(yong)藥(yao)為(wei)開發的方(fang)向,發展多劑型并存,大力發展無(wu)菌(jun)水(shui)針劑及無(wu)菌(jun)滴眼(yan)液(ye)(ye)(ye)。同時(shi)結合水(shui)針劑重點產(chan)(chan)品(pin)(pin)開發原(yuan)料(liao)藥(yao),實(shi)現(xian)從原(yuan)料(liao)到(dao)制劑的產(chan)(chan)業鏈配套生(sheng)產(chan)(chan),建立起品(pin)(pin)種、技(ji)術與(yu)品(pin)(pin)牌優(you)勢(shi)。努(nu)力提高(gao)現(xian)有(you)(you)(you)產(chan)(chan)品(pin)(pin)的技(ji)術水(shui)平(ping),降低成(cheng)本,同時(shi)以現(xian)有(you)(you)(you)生(sheng)產(chan)(chan)設施(shi)為(wei)依托,以市場需(xu)求為(wei)導(dao)向,積(ji)極(ji)尋(xun)求具有(you)(you)(you)比較優(you)勢(shi)的新(xin)產(chan)(chan)品(pin)(pin)。
公司生(sheng)(sheng)產(chan)大容(rong)量(liang)(liang)(liang)注(zhu)射(she)劑(ji)、小容(rong)量(liang)(liang)(liang)注(zhu)射(she)劑(ji)、粉針劑(ji)、片劑(ji)、顆粒(li)劑(ji)、膠囊劑(ji)等六個劑(ji)型近200種(zhong)產(chan)品和(he)中藥(yao)提取物。我公司以大容(rong)量(liang)(liang)(liang)注(zhu)射(she)劑(ji)和(he)小容(rong)量(liang)(liang)(liang)注(zhu)射(she)劑(ji)為主(zhu),做專業的注(zhu)射(she)劑(ji)藥(yao)品生(sheng)(sheng)產(chan)商。大容(rong)量(liang)(liang)(liang)注(zhu)射(she)液(ye)產(chan)品齊全,多種(zhong)包裝(zhuang)形式并(bing)存,在PP瓶、軟袋(dai)、玻璃瓶輸液(ye)的基礎(chu)上(shang),向雙室袋(dai)、多室袋(dai)等國際(ji)先(xian)進的輸液(ye)包裝(zhuang)形式發展。小容(rong)量(liang)(liang)(liang)注(zhu)射(she)劑(ji)在玻璃安瓿的基礎(chu)上(shang),大力發展塑瓶(PP和(he)PE)安瓿及(ji)西林瓶小水針劑(ji)。積極謀求國際(ji)高端(duan)GMP認證(zheng),由內(nei)銷(xiao)為主(zhu)向內(nei)銷(xiao)與(yu)出口并(bing)重轉(zhuan)變。